GSK Gets A Lucky Q1 Boost, But All Eyes Are On RSV Vaccine Readout

Revenues Up By 32%

 
• By Andrew McConaghie
GSK Skyline
GlaxoSmithKline will spin out its consumer health division in July - by which time its RSV vaccine results should also be ready. • Source: Alamy

More from Business

More from Scrip